His primary scientific interests are in Randomized controlled trial, Intensive care, Anesthesia, Intensive care medicine and Intensive care unit. His study with Randomized controlled trial involves better knowledge in Internal medicine. He has researched Internal medicine in several fields, including Placebo and Endocrinology.
The concepts of his Anesthesia study are interwoven with issues in Vasopressin, Red blood cell and Surgery. His Intensive care medicine study integrates concerns from other disciplines, such as Resuscitation, Antibody and Retrospective cohort study. His Intensive care unit research integrates issues from Hypoglycemia, Mechanical ventilation, Confidence interval and Emergency medicine.
His scientific interests lie mostly in Intensive care medicine, Randomized controlled trial, Intensive care, Internal medicine and Anesthesia. The study incorporates disciplines such as Septic shock, Anemia, Blood transfusion and MEDLINE in addition to Intensive care medicine. His Randomized controlled trial study combines topics in areas such as Resuscitation, Intensive care unit and Clinical trial.
His Intensive care unit study frequently links to other fields, such as Emergency medicine. His work deals with themes such as Red cell transfusion, Cohort study, Pediatrics and Prospective cohort study, which intersect with Intensive care. His Cardiology research extends to the thematically linked field of Internal medicine.
His primary areas of study are Internal medicine, Randomized controlled trial, Emergency medicine, Intensive care medicine and MEDLINE. The various areas that Paul C. Hébert examines in his Internal medicine study include Surgery and Cardiology. Paul C. Hébert has included themes like Shock, Critically ill, Intensive care unit and Anesthesiology in his Randomized controlled trial study.
His Intensive care unit research incorporates themes from Mortality rate and Red blood cell. His biological study spans a wide range of topics, including Psychological intervention, Mechanical ventilation, Intensive care, Retrospective cohort study and Severity of illness. His Intensive care medicine study incorporates themes from Clinical epidemiology, Case-control study and Blood transfusion.
The scientist’s investigation covers issues in Randomized controlled trial, Internal medicine, MEDLINE, Intensive care medicine and Shock. His Randomized controlled trial research includes elements of Anesthesia and Critically ill. Paul C. Hébert interconnects Hypoglycemia, Insulin, Odds ratio and Young adult in the investigation of issues within Anesthesia.
His Internal medicine study which covers Cardiology that intersects with APACHE II and Norepinephrine. His studies deal with areas such as Cross-sectional study and Adult patients as well as MEDLINE. In his research, Disseminated intravascular coagulation, Heparin, Interquartile range and Meta-analysis is intimately related to Septic shock, which falls under the overarching field of Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.
Paul C. Hébert;George Wells;Morris A. Blajchman;John Marshall.
The New England Journal of Medicine (1999)
Intensive versus conventional glucose control in critically ill patients.
Nice-Sugar Study Investigators;D. Chittock;S. Su;D. Blair.
The New England Journal of Medicine (2009)
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Rajiv Saran;Bruce Robinson;Kevin C. Abbott;Lawrence Y.C. Agodoa.
American Journal of Kidney Diseases (2017)
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
Jeffrey L Carson;Simon J Stanworth;Nareg Roubinian;Dean A Fergusson.
Cochrane Database of Systematic Reviews (2016)
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
James A. Russell;Keith R. Walley;Joel Singer;Anthony C. Gordon.
The New England Journal of Medicine (2008)
A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
Dean A. Fergusson;Paul C. Hébert;C. David Mazer;Stephen Fremes.
The New England Journal of Medicine (2008)
Hypoglycemia and risk of death in critically ill patients.
Simon R Finfer;Bette Liu;Dean R Chittock;Robyn Norton.
The New England Journal of Medicine (2012)
Transfusion Strategies for Patients in Pediatric Intensive Care Units
Jacques Lacroix;Paul C. Hébert;James S. Hutchison;Heather A. Hume.
The New England Journal of Medicine (2007)
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases
Paul C. Hébert;Elizabeth Yetisir;Claudio Martin;Morris A. Blajchman.
Critical Care Medicine (2001)
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis
Dean Fergusson;Shawn D Aaron;Gordon Guyatt;Paul Hébert.
BMJ (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Ottawa Hospital
McMaster University
Harvard University
McMaster University
University of Ottawa
University of Ottawa
Ottawa Hospital
Ottawa Hospital
University of Toronto
McMaster University
Grenoble Alpes University
Technical University of Munich
Clemson University
University of Utah
University of Tennessee at Knoxville
University of Hawaii at Manoa
University of Wisconsin–Madison
University of Queensland
Université Catholique de Louvain
University of Groningen
University of Toronto
National Institutes of Health
Harvard Medical School
Chennai Institute of Technology
University of Huddersfield
Michigan State University